DOI: 10.1007/s00259-018-4162-5Pages: 1-3

The influence of PSA flare in mCRPC patients treated with alpha-emitting radiopharmaceuticals

1. University of California Los Angeles (UCLA), Ahmanson Imaging Translational Division, Department of Molecular and Medical Pharmacology

2. S.Orsola-Malpighi University Hospital, University of Bologna, Metropolitan Nuclear Medicine

Correspondence to:
Francesco Ceci
Email: fceci@mednet.ucla.edu

Close

Abstract

This article is freely available, click here to access the full text/PDF

  • Online: Sep 19, 2018

Article Tools

eanm
EJNMMI Ad